Latest News about Biotech and Pharmaceuticals
Recent news which mentions Biotech and Pharmaceuticals
From CNBC.com News
Walgreens tops quarterly revenue estimates, but narrows profit outlook in 'challenging' economy
March 28, 2024
From CNBC.com News
Altimmune says weight loss drug minimized muscle loss in trial results that may set it apart
March 27, 2024
From CNBC.com News
Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
March 27, 2024
From CNBC.com News
Moderna moves three vaccines into final stage trials as it works to rebound from Covid slump
March 27, 2024
From CNBC.com News
FDA approves Merck's drug for rare, deadly lung condition
March 26, 2024
From CNBC.com News
Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients
March 26, 2024
From CNBC.com News
Moderna says new Covid vaccine showed stronger immune response than current shot in study
March 26, 2024
From CNBC.com News
From CNBC.com News
Amgen wants in on the booming weight loss drug market — and it's taking a different approach
March 24, 2024
From CNBC.com News
Here's how much people are willing to spend on weight loss drugs, according to a new survey
March 23, 2024
From CNBC.com News
From CNBC.com News
FDA says safety issues with China-made syringes are 'more widespread' than previously known
March 20, 2024
From CNBC.com News
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
March 19, 2024
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free